CannaTech

JULY 15, 2018

This is the title that the media chose to report the studies findings: “ Australian Study Finds No Strong Evidence That Cannabis Use Reduces Pain or Opioid Use in People Living With Chronic Non-Cancer Pain.” While we applaud the authors and their work, the sensationalist title the media picked up is beyond misleading.

Media 94

Media Treatment Cannabinoids Programs 94

Cannabis Law Report

NOVEMBER 17, 2021

There is one problem, Malaysia currently has no registered cannabis-based treatment. In a press event, public health minister, Anutin Charnvirakul said that the ministry would promote medical cannabis to help people access treatment safely and within the law. Importers would be required to hold permits and licenses.

Research and Development 111

Research and Development Treatment Patients Pharmaceutical 111

MMJ Recs

MAY 1, 2024

Through community outreach, social media campaigns, educational seminars, and mental health screenings, the month seeks to empower individuals to seek help when needed, cultivate supportive environments, and advocate for policies that promote mental health equity and access to care.

Marijuana 105

Marijuana Treatment Conditions Chronic Pain 105

NORML

OCTOBER 30, 2019

With Nevada NORML’s Virtual Lobby Day, volunteers will be utilizing a variety of communication mediums, from letter writing campaigns to phone banking and social media, to contact their representatives to demonstrate support for these federal bills. ” said Nevada NORML Director Madisen Saglibene.

Media 104

Media Legislation Events Banking 104

Cannabis Law Report

JULY 22, 2021

A master distribution agreement has been signed with My Green Planet, a leading global agricultural supply group, giving Sporeo access to approximately 7,000 retailers across North America, Australia, and Europe. Levitee Labs aims to catalyze access to compounds and alternative medicines that enhances the wellbeing of society.

eCommerce 105

eCommerce Therapy Media Access 105

NORML

NOVEMBER 5, 2019

With Nevada NORML’s Virtual Lobby Day, volunteers will be utilizing a variety of communication mediums, from letter writing campaigns to phone banking and social media, to contact their representatives to demonstrate support for these federal bills. ” said Nevada NORML Director Madisen Saglibene.

Media 100

Media Legislation Events Banking 100

Veriheal

OCTOBER 1, 2020

Cannabis is easily accessible, and the regulations are loosening up quite a bit. In 2018, the government was confronted by a media storm that has called for them to act. The media storm came about as 12-year-old Billy Caldwell and 6-year-old Alfie Dingley were being denied cannabis oil as a treatment for their epilepsy.

Legalization 105

Legalization Oil Medicine Media 105

Veriheal

SEPTEMBER 22, 2020

The list, curated by The Root annually, honors Black leaders and trailblazers making history across industries and communities within arts, entertainment, media, politics, STEM, sports, and more. . At Veriheal, we are truly honored and privileged to have two Black leaders. The Root says it perfectly: .

Education 98

Education Banking History Media 98

Cannabis Law Report

SEPTEMBER 1, 2021

In countries where medical cannabis is legal, patients have more treatment options to choose from. Patients in the UK who are suffering from epilepsy, multiple sclerosis, insomnia, chronic pain, anxiety, and other medical conditions can use medical cannabis as an adjunct or alternative treatment.

Legalization 109

Legalization Marijuana Treatment Patients 109

Cannabis Law Report

FEBRUARY 20, 2020

by Rachel Garland, Green-Flower Media. Pharmacopeia as a treatment for several conditions including: tetanus, gout, tonsillitis, alcoholism, menstrual cramps, cholera, arthritis, and many others. 9 Things You Never Knew about Cannabis Tinctures. Cannabis tinctures are one of the best, most underrated delivery methods for cannabis.

Tincture 59

Tincture Media Cannabinoids Topical 59

Cannabis Law Report

JANUARY 3, 2022

The Czech Republic legalized therapeutic cannabis for selected patients in 2015, and health insurance companies have been covering up to 90% of the cost of the treatment since 2020. According to official data cited by the Czech News Agency (CTK), the treatment helped improve the health condition and well-being of patients in 69% of cases.

Media 52

Media Chronic Pain Patients Treatment 52

Veriheal

DECEMBER 4, 2023

Let’s take a look at how businesses are parting ways with traditional “cannabis tests” as well as how legal access leads to fair employment opportunities for consumers alike. Do not attempt to self-diagnose or prescribe treatment based on the information provided.

Policy 119

Policy Safety Treatment Business 119

Puff Puff Post

MARCH 21, 2019

On March 8, the FDA granted the accelerated approval of Roche’s programmed cell death protein 1 (PD-1) inhibitor Tecentriq in combination with Abraxane (protein-bound paclitaxel) for the treatment of locally advanced or metastatic triple-negative breast cancer (TNBC). To gain access to our latest press releases: GlobalData Media Centre.

Data 92

Data Treatment Media Patients 92

Veriheal

JANUARY 4, 2021

In adults with chronic pain , what are the harms of Kratom or other plant-based substances for treatment of chronic pain? In adults with chronic pain, what are the benefits of Kratom or other plant-based substances for treatment of chronic pain? In adults with chronic pain, what are the harms of cannabinoids? A Statement from the AHRQ.

Chronic Pain 105

Chronic Pain Therapy Cannabinoids Treatment 105

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. The call can be accessed by dialing (833) 665-0659 from the United States, +1 (914) 987-7313 internationally, and 0800 028 8438 from the UK, followed by the conference ID: 3495828.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

AUGUST 24, 2022

Magic mushrooms have been undergoing a transformation from illicit recreational drug popularised by Timothy Leary and Aldous Huxley to promising mental health treatment with restrictions starting to lift in some countries. People are going underground to get access and we’re still not allowing the research to happen. It’s crazy.”.

Medicine 52

Medicine Media Chronic Pain Treatment 52

CannaMD

NOVEMBER 6, 2019

Perhaps the commercialization of marijuana and the favorable media coverage surrounding the health effects of marijuana are fostering such a perception. As more people gain access to medical marijuana, dependence on opioids for pain relief is likely to decline. Medical cannabis is an effective and safe alternative for pain treatment.

Marijuana 107

Marijuana Patients Clinical Trials Data 107

Cannabis Law Report

JUNE 5, 2021

Founded by women, and focused on addressing women’s mental and physical health with psychedelic enhanced treatments, the company has developed a two pronged approach, with a long term drug discovery program to bring an FDA approved drug to market. About Aphrodite Health.

Research and Development 90

Research and Development Medicine Treatment Programs 90

Cannabis Law Report

JULY 24, 2021

This expansive patent would allow Mydecine to scale its coverage in drug development research in lieu of promising discoveries and FDA-approval progress for novel therapeutics, including granting Breakthrough Therapy Designation to MDMA for the treatment of PTSD in recent years. For more information, please contact: Media Contacts.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Canna Law Blog

APRIL 13, 2019

The letters were sent “in response to their making unsubstantiated claims related to more than a dozen different products and spanning multiple product webpages, online stores and social media websites.” Specifically, the agency fears that.

CBD 103

CBD Safety Topical Food 103

Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. For more than a year, the Department of Health has fought to keep that information secret.

Data 52

Data Treatment Patients Chronic Pain 52

Cannabis Law Report

OCTOBER 5, 2021

Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions. An evaluation of the therapeutic value, benefits and risks of methylenedioxymethamphetamine (MDMA) and psilocybin for the treatment of mental, behavioural or developmental disorders.

Treatment 52

Treatment Conditions Medicine Clinical Trials 52

CannaMD

MARCH 8, 2021

1455 covers three major themes: medical marijuana advertising, THC potency/access to high-THC products, and administrative issues. Prohibiting a medical marijuana treatment center from dispensing marijuana that exceeds a certain potency of tetrahydrocannabinol [p. Food & Drug Association’s role in H.B. Florida H.B.

THC 116

THC Research and Development Treatment Patients 116

Veriheal

MARCH 1, 2022

The campaign manager of the ‘Yes on 109’ campaign that helped see the measure passed, Sam Chapman, told media sources, “There’s a huge breadth of expertise on this board from harm reduction experts to folks that have experience working with different populations that stand to benefit from having access to psilocybin therapy.

Therapy 98

Therapy Programs Microdosing Medicine 98

MMJ Recs

AUGUST 23, 2024

Traditional medications often provide limited relief, leading many sufferers to explore alternative treatment options. In this article, we’ll explore the role of medical cannabis in migraine relief, its effectiveness, and considerations for using it as an alternative treatment route.

Marijuana 98

Marijuana Strains Indica Sativa 98

Cannabis Law Report

AUGUST 25, 2021

As the nation’s leading nonprofit provider of comprehensive inpatient and outpatient addiction and mental health care for adults and youth, the Foundation has treatment centers and telehealth services nationwide as well as a network of collaborators throughout health care. Learn more at HazeldenBettyFord.org and on Twitter.

Education 81

Education Programs Research and Development Treatment 81

Cannabis Law Report

NOVEMBER 23, 2021

London, UK – 23 November 2021 COMPASS Pathways plc a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it has been granted its fifth patent by the US Patent and Trademark Office. PRESS RELEASE.

Clinical Trials 52

Clinical Trials Therapy Research and Development Media 52

Cannabis Law Report

SEPTEMBER 22, 2022

The Federal Parliament legalised the use of medicinal cannabis products in Australia in February 2016, but access to treatment is still severely limited due to cost, with patients reporting average monthly costs in excess of $300 , or approximately $10 per day. Also read media report at. He writes on his website.

Pharmaceutical 52

Pharmaceutical Media Medicine Treatment 52

Cannabis Law Report

SEPTEMBER 20, 2021

KWC is a limited liability corporation formed under the laws of Arizona , which operates 10 ketamine infusion treatment clinics, across Arizona , Colorado , Florida , Illinois , Minnesota , Nevada , Texas , and Washington. Transaction Highlights.

Treatment 52

Treatment Media Research and Development Patients 52

Cannabis Law Report

NOVEMBER 9, 2021

(“Delic” or the “Company”) (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (Original Source), a leader in new medicines and treatments for a modern world, today announced the official, completed acquisition of Ketamine Wellness Centers Arizona LLC (“KWC”), becoming the largest chain of wellness centers providing ketamine treatments in the U.S.

Treatment 52

Treatment Therapy Media Access 52

Cannabis Law Report

MARCH 12, 2020

Ganjapreneur report… Two bills aiming to improve veterans’ access to medical cannabis have passed through the House Veterans’ Affairs Committee this week. The House Veterans’ Affairs Committee has advanced two separate pieces of legislation that address veterans’ access to medical cannabis, Marijuana Moment reports.

Media 59

Media Access Legislation Cannabis 59

Cannabis Law Report

OCTOBER 22, 2021

Medicines and Healthcare products Regulatory Agency (the “ MHRA ”), Small Pharma has been granted an Innovation Passport Designation for SPL026, the lead product candidate from its pipeline of N,N-dimethyltryptamine (“ DMT ”) assisted therapies for the treatment of major depressive disorder (“ MDD ”). About Small Pharma.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

MMJ Recs

MAY 3, 2024

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

Cannabis Law Report

JULY 6, 2021

Johnson’s primary area of research expertise is the psychopharmacology of medications for treating addictions, and he is well known in the field for his discovery that topiramate, a gamma-aminobutyric acid (GABA) facilitator and glutamate antagonist, an effective treatment for alcoholism. ” About Ehave, Inc. Ehave, Inc.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

Cannabis Law Report

NOVEMBER 16, 2019

Current barriers to patient access to medicinal cannabis in Australia. On 14 November 2019, the Senate referred an inquiry into the current barriers to patient access to medicinal cannabis in Australia to the Senate Community Affairs References Committee for inquiry and report by 12 February 2020. Media Releases. Accessibility.

Clinical Trials 58

Clinical Trials Access Medicine Patients 58

Cannabis Law Report

AUGUST 21, 2019

Cannabis treatments are too expensive and do not come with enough test evidence to be effective, UK authorities have said. It also said current treatments for adults suffering severe symptoms were “not cost effective”. If you wish to re-publish this story please do so with following accreditation. AUTHOR: Mark Taylor.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

Veriheal

MAY 17, 2021

Other states have gone beyond just medical access and have also legalized retail cannabis markets for adult consumers. Theodore happens to also be an addiction expert who refuses to provide treatment to patients that choose to consume cannabis as he believes it interferes with the treatment of other addictions.

Legalization 93

Legalization Pharmaceutical Therapy Chronic Pain 93